|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Peripheral Vascular Diseases | |||||
| Thromboembolism | |||||
| Vascular Diseases | |||||
| Venous Thromboembolism | |||||
| 2 | More general conditions related to this trial | ||||
| Embolism and Thrombosis | |||||
| Thrombosis | |||||
| 3 | Interventions listed in this trial | ||||
| warfarin | |||||
| 4 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||